18 month clinical outcome after implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes - a SORT OUT III substudy

Michael Mæng, Lisette Okkels Jensen, Hans-Henrik Tilsted Hansen, Anne Kaltoft, P Thayssen, Anders Michael Galløe, Evald Høj Christiansen, Henning Skov Kelbæk, Lars Romer Krusell, Jan Ravkilde, Henrik Toft Sørensen, Leif Thuesen, Jens Flensted Lassen

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date2010
Number of pages1
Publication statusPublished - 2010
Externally publishedYes
EventTCT 2010 - Washington DC
Duration: 21 Sep 201025 Sep 2010

Conference

ConferenceTCT 2010
CityWashington DC
Period21/09/201025/09/2010

Cite this

Mæng, M., Jensen, L. O., Hansen, H-H. T., Kaltoft, A., Thayssen, P., Galløe, A. M., Christiansen, E. H., Kelbæk, H. S., Krusell, L. R., Ravkilde, J., Sørensen, H. T., Thuesen, L., & Lassen, J. F. (2010). 18 month clinical outcome after implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes - a SORT OUT III substudy. Poster presented at TCT 2010, Washington DC, .